Evidence map›Paper›PMID 24748274›Full record

ArticlePloS one2014

Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades.

Yaxelis Mendoza, Alexander A Martínez, Juan Castillo Mewa, Claudia González, Claudia García-Morales, Santiago Avila-Ríos, Gustavo Reyes-Terán, Blas Armién, Juan M Pascale, Gonzalo Bello

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. The Immune Modulatory Role of TIF1 Proteins.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Identification of major routes of HIV transmission throughout Mesoamerica.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Yaxelis MendozaDepartment of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama; Department of Biotechnology, Acharya Nagarjuna University, Guntur City, Andhra Pradesh, India; Department of Genetics and Molecular Biology, University of Panama, Panama City, Panama; INDICASAT-AIP, City of Knowledge, Clayton, Panama City, Panama.
Alexander A MartínezDepartment of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama; Department of Biotechnology, Acharya Nagarjuna University, Guntur City, Andhra Pradesh, India; INDICASAT-AIP, City of Knowledge, Clayton, Panama City, Panama.
Juan Castillo MewaDepartment of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Claudia GonzálezDepartment of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Claudia García-MoralesCentro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Santiago Avila-RíosCentro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Gustavo Reyes-TeránCentro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Blas ArmiénDepartment of Emerging and Zoonotic Infectious Diseases, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Juan M PascaleDepartment of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Gonzalo BelloLaboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Instituto Conmemorativo Gorgas de Estudios de la Salud · PAInstituto Nacional de Enfermedades Respiratorias · MXCity of Knowledge · PAFundação Oswaldo Cruz · BRInstituto de Investigaciones Científicas y Servicios de Alta Tecnología · PA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human immunodeficiency virus type-1 (HIV-1) subtype B is the most predominant clade in Central America; but information about the evolutionary history of this virus in this geographic region is scarce. In this study, we reconstructed the spatiotemporal and population dynamics of the HIV-1 subtype B epidemic in Panama. A total of 761 HIV-1 subtype B pol sequences obtained in Panama between 2004 and 2013 were combined with subtype B pol sequences from the Americas and Europe. Maximum Likelihood phylogenetic analyses revealed that HIV-1 subtype B infections in Panama derived from the dissemination of multiple founder viruses. Most Panamanian subtype B viruses (94.5%) belong to the pandemic viral strain proposed as originated in the US, whereas others (5.5%) were intermixed among non-pandemic Caribbean strains. The bulk (76.6%) of subtype B sequences from Panama grouped within 12 country-specific clades that were not detected in other Central American countries. Bayesian coalescent-based analyses suggest that most Panamanian clades probably originated between the early 1970s and the early 1980s. The root location of major Panamanian clades was traced to the most densely populated districts of Panama province. Major Panamanian clades appear to have experienced one or two periods of exponential growth of variable duration between the 1970s and the 2000s, with median growth rates from 0.2 to 0.4 year(-1). Thus, the HIV-1 subtype B epidemic in Panama is driven by the expansion of local viral strains that were introduced from the Caribbean and other American countries at an early stage of the AIDS pandemic.

Indexed as

HIV-1HIV InfectionsHumansPanamaPhylogeny

Identifiers

PMID24748274
PMCPMC3991702
OpenAlexW2074798723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.